Guest guest Posted July 11, 2010 Report Share Posted July 11, 2010 J posted this back in 08. http://ajpheart.physiology.org/cgi/content/full/289/2/H558 ELEVATED MMP-9 http://ajpheart.physiology.org/cgi/content/full/289/2/H558 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 12, 2010 Report Share Posted July 12, 2010 Thanks k,good find, > > J posted this back in 08. > > http://ajpheart.physiology.org/cgi/content/full/289/2/H558 > > > ELEVATED MMP-9 > > http://ajpheart.physiology.org/cgi/content/full/289/2/H558 > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 12, 2010 Report Share Posted July 12, 2010 check out some of the cited abstracts on this. Blood–Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9 Conclusions— Baseline MMP-9 was a significant predictor of HARM at 24-hour follow-up, supporting the hypothesis that MMP-9 is associated with BBB disruption. If the association between MMP-9 and BBB disruption is confirmed in future studies, HARM may be a useful imaging marker to evaluate MMP-9 inhibition in ischemic stroke and other populations with BBB disruption. http://stroke.ahajournals.org/cgi/content/abstract/41/3/e123 Systemic Inflammation Alters the Kinetics of Cerebrovascular Tight Junction Disruption after Experimental Stroke in Mice Systemic inflammatory events, such as infection, increase the risk of stroke and are associated with worse outcome. Systemic inflammation caused an alteration in the kinetics of blood–brain barrier (BBB) disruption through conversion of a transient to a sustained disruption of the tight junction protein, claudin-5, and also markedly exacerbated disruption to the cerebrovascular basal lamina protein, collagen-IV. These alterations were associated with a systemic inflammation-induced increase in neurovascular gelatinolytic activity that was mediated by a fivefold increase in neutrophil-derived matrix metalloproteinase-9 (MMP-9). Specific inhibition of MMP-9 abrogated the effects of systemic inflammation on the sustained but not the acute disruption of claudin-5, which was associated with phosphorylation of cerebrovascular myosin light chain. MMP-9 inhibition also attenuated the deleterious impact of systemic inflammation on brain damage, edema, neurological deficit, and incidence of hemorrhagic transformation. These data indicate that a transformation from transient to sustained BBB disruption caused by enhanced neutrophil-derived neurovascular MMP-9 activity is a critical mechanism underlying the exacerbation of ischemic brain injury by systemic inflammation. http://www.jneurosci.org/cgi/content/abstract/28/38/9451 > > > > > J posted this back in 08. > > > > http://ajpheart.physiology.org/cgi/content/full/289/2/H558 > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.